RAIN

Rain Enhancement Technologies Holdco, Inc.

Nasdaq · Misc Industrial & Commercial Machinery & Equipment · Inc. MA · CIK 0002028293
$1.98 -5.26% $17.1M
Vol
Market Cap$17.1M
Cap SizeNano Cap
Inst. Holders3 funds
Inst. Value$310.5K
Inst. Activity1 buys / 0 sells
Insider Activity3B / 0S
Insider Net $$100.9K
Reddit Sentiment67° Warm
Exchange Nasdaq·Sector Misc Industrial & Commercial Machinery & Equipment·Inc. MA·CIK 0002028293·Prev Close $2.09

Recent Activity

Jun 5, 2026 Insider
Sylvester David C sold 40,000 shares
Director @ $0.00 ($0.00)
Jun 5, 2026 Insider
Steele Alexandra sold 80,000 shares
Director @ $0.00 ($0.00)
Jun 5, 2026 Insider
Riley Christopher Michael sold 50,000 shares
Director @ $0.00 ($0.00)
Inst.
VANGUARD GROUP INC — ADD
45,102 shares ($263.4K)
Inst.
VANGUARD GROUP INC — NEW
25,873 shares ($143.1K)

Analyst Ratings

Historical distribution0% buy · 11 analysts · no recent coverage
0Strong Buy
0Buy
8Hold
1Sell
2Strong Sell

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$263.4KADD
BANK OF AMERICA CORP$42.7KDOUBLED
MORGAN STANLEY$4.4K

Recent Insider Trades

DateInsiderTypeValue
Jun 5, 2026Sylvester DavidA$0.00
Jun 5, 2026Steele AlexandraA$0.00
Jun 5, 2026Riley ChristopherA$0.00
Jun 5, 2026DICKERSON LYMANA$0.00
Jun 5, 2026Reardon RobertA$0.00

Reddit Sentiment

67°
Warm
Bearish Neutral Bullish
2 mentions 2 bullish 0 bearish
3 institutional holders with $310.5K total value (53,170 shares) as of 2025-Q4. Top holders: VANGUARD, BANK, MORGAN. Net buying activity: 1 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC45,102$263.4K84.8%ADD +74.3%
2BANK OF AMERICA CORP /DE/7,318$42.7K13.8%DOUBLED +38985.0%
3MORGAN STANLEY750$4.4K1.4%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
VANGUARD GROUP INCADD25,87345,102+74.3%$263.4K2025-Q4
VANGUARD GROUP INCNEW25,873$143.1K2025-Q3
BANK OF AMERICA CORP /DE/DOUBLED207,817+38985.0%$43.2K2025-Q3
UBS Group AGDOUBLED11,38489,409+685.4%$268.2K2025-Q2
UBS Group AGNEW11,384$22.5K2025-Q1
9 unique insiders with 3 transactions. Net insider value: $100.9K ($100.9K bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 5, 2026Sylvester David CDirectorA40,000$0.00$0.00
Jun 5, 2026Steele AlexandraDirectorA80,000$0.00$0.00
Jun 5, 2026Riley Christopher MichaelDirectorA50,000$0.00$0.00
Jun 5, 2026DICKERSON LYMAN BDirectorA80,000$0.00$0.00
Jun 5, 2026Reardon RobertDirectorA80,000$0.00$0.00
Jun 5, 2026PEPERZAK MARCUSDirectorA80,000$0.00$0.00
Jun 5, 2026Truong OanhInterim CFOA50,000$0.00$0.00
Jun 5, 2026You Harry L.DirectorA1,612,903$0.00$0.00
May 22, 2025Seidl RandyChief Executive OfficerBUY4,000$2.58$10.3K
May 21, 2025Seidl RandyChief Executive OfficerBUY30,000$2.53$75.9K
May 20, 2025Seidl RandyChief Executive OfficerBUY8,514$1.73$14.7K

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution: 0% buy across 11 analysts — 0 strong buy, 0 buy, 8 hold, 1 sell, 2 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Feb 1, 2024008120%
Jan 1, 2024008120%
Dec 1, 20230011120%
Nov 1, 20230011120%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

67°
Warm
Bearish Neutral Bullish
2 mentions 2 bullish 0 bearish 2 time periods

Reddit Sentiment History

DateMentionsSentimentBullishBearishThreads
Jun 2, 2026160° Warm101
Jun 2, 2026160° Warm101

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.